Clinical Trial

Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if a GalKO Porcine Thymokidney can maintain renal function, without the need for dialysis, after transplantation into adult subjects with End Stage Renal Disease.
Trial Details
NCT Number NCT07696962
Lead Sponsor Xeno Holdings (US), LLC dba ChoironeX
Conditions End Stage Renal Disease
Enrollment 4 participants
Start Date 2026-07-01
Primary Completion 2028-05-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-10